Search Count: 15
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2025-03-05 Classification: TRANSFERASE Ligands: A1AF6 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2024-08-07 Classification: APOPTOSIS Ligands: A1ALT |
 |
Crystal Structure Of Human Wd Repeat-Containing Protein 5 In Complex With 4-(3,5-Dimethoxybenzyl)-9-(4-Fluoro-2-Methylphenyl)-7-((2-Imino-3-Methyl-2,3-Dihydro-1H-Imidazol-1-Yl)Methyl)-3,4-Dihydrobenzo[F][1,4]Oxazepin-5(2H)-One (Compound 8)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2023-12-20 Classification: TRANSCRIPTION Ligands: VV3 |
 |
Wd Repeat-Containing Protein 5 Complexed With 4-(7-((1H-Imidazol-1-Yl)Methyl)-5-(1-Methyl-3-(Trifluoromethyl)-1H-Pyrazol-4-Yl)-1-Oxo-3,4-Dihydroisoquinolin-2(1H)-Yl)-6-Ethyl-N-Methylquinoline-8-Carboxamide (Compound 10)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2023-01-11 Classification: TRANSCRIPTION Ligands: BEN, UY9 |
 |
Discovery Of Potent Orally Bioavailable Wd Repeat Domain 5 (Wdr5) Inhibitors Using A Pharmacophore-Based Optimization
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2022-05-04 Classification: Transcription/Transcription Inhibitor Ligands: MBU |
 |
Wdr5 Bound To 2-(3,5-Dimethoxybenzyl)-7-((2-Methyl-1H-Imidazol-1-Yl)Methyl)-5-(1-Methyl-3-(Trifluoromethyl)-1H-Pyrazol-4-Yl)-3,4-Dihydroisoquinolin-1(2H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2022-04-27 Classification: Transcription/Transcription Inhibitor Ligands: BEN, M4U |
 |
Crystal Structure Of Ldha In Complex With Compound Ncgc00384414-01 At 2.05 A Resolution
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2020-09-23 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor Ligands: PO4, P8M, NAI, GOL |
 |
Crystal Structure Of Ldha In Complex With Compound Ncgc00420737-09 At 2.00 A Resolution
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-09-23 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor Ligands: NAI, P8V, EDO |
 |
Discovery And Structure-Based Optimization Of Potent And Selective Wdr5 Inhibitors Containing A Dihydroisoquinolinone Bicyclic Core
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2020-01-01 Classification: TRANSCRIPTION Ligands: Q41 |
 |
Wd Repeat-Containing Protein 5 Complexed With N-[(3,5-Dimethoxyphenyl)Methyl]-4'-Fluoro-5-{[(2E)-2-Imino-3-Methyl-2,3-Dihydro-1H-Imidazol-1-Yl]Methyl}-2'-Methyl[1,1'-Biphenyl]-3-Carboxamide (Compound 13)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2020-01-01 Classification: GENE REGULATION/INHIBITOR Ligands: Q6S |
 |
Crystal Structure Of Lactate Dehydrogenase A In Complex With Inhibitor Compound 11
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-01-17 Classification: OXIDOREDUCTASE Ligands: 9Y1, ACT, DMS, MLA, GOL |
 |
Crystal Structure Of Lactate Dehydrogenase A In Complex With Inhibitor Compound 23 And Zinc
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2018-01-17 Classification: OXIDOREDUCTASE Ligands: ZN, 9YD, CIT, DMS, MLA, GOL |
 |
Crystal Structure Of Lactate Dehydrogenase A In Complex With Inhibitor Compound 29
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2018-01-17 Classification: OXIDOREDUCTASE Ligands: 9Y7, MLA, DMS, GOL |
 |
Crystal Structure Of Lactate Dehydrogenase A In Complex With Inhibitor Compound 29 And Nadh
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2018-01-17 Classification: OXIDOREDUCTASE Ligands: 9Y7, NAI, MLA, GOL |
 |
Crystal Structure Of Lactate Dehydrogenase A In Complex With Inhibitor Compound 59 And Nadh
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2018-01-17 Classification: OXIDOREDUCTASE Ligands: NAI, 9YA, EDO |